Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Change in Acquisitions & Divestments (2024 - 2025)

Hinge Health's Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $118.8 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 46.29% year-over-year to $118.8 million; the TTM value through Dec 2025 reached $369.1 million, changed N/A, while the annual FY2025 figure was $368.6 million, 6.34% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $118.8 million at Hinge Health, up from $85.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $118.8 million in Q4 2025 and bottomed at $81.2 million in Q4 2024.